You are here

4 - In vivo Proof-of-Principle

avB6-binding Peptides for Tumour Targeting

The integrin ɑvß6 is an exciting emerging target for both imaging and therapy across many common tumour types including pancreatic, breast, oesophagus, head and neck, skin, lung and ovarian. Patent family WO2007/039728 protecting the peptide consensus sequence is available for exclusive licensing or collaborative development.

Subscribe to RSS - 4 - In vivo Proof-of-Principle